ATRA vs BROS · rev $128.9M vs P/E 105, rev $1.28B
Atara Biotherapeutics Inc (ATRA) versus Dutch Bros Inc (BROS) — a side-by-side from cached financials, not a winner call.
Atara Biotherapeutics Inc (ATRA) is a biotechnology company listed on NASDAQ.
Dutch Bros Inc (BROS) is a restaurants company listed on NYSE.
Latest reported ATRA revenue for 2024-12-31 was $128.9M. Net income was -$85.4M. Revenue was up 1404.0% from 2023-12-31 to 2024-12-31. ATRA currently screens at market cap $87.1M.
Latest reported BROS revenue for 2024-12-31 was $1.28B. Net income was $66.5M. Revenue was up 32.6% from 2023-12-31 to 2024-12-31. BROS currently screens at market cap $11.74B and trailing P/E 105.0.
ATRA currently screens at market cap $87.1M. BROS currently screens at market cap $11.74B and trailing P/E 105.0.
Not investment advice. Open the ATRA and BROS stock pages for the full models.
Not investment advice.